InsidersTradesSigma
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Frieson Ron, 董事. Insider active across 1 company, notably Akebia Therapeutics, Inc.. Aggregated, 5 disclosures have been published. Activity tracked since 8 June 2022. The latest transaction was disclosed on 17 January 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Ron Frieson is a Director at Akebia Therapeutics, Inc. He contributes to corporate governance and the strategic direction of the company. As a board member, he participates in important decision-making and oversight of Akebia's operations. His experience in the biopharmaceutical sector is an asset for the company.